DALLAS, May 1, 2015 /PRNewswire/ --
The report "Pharmaceutical Grade Sodium Chloride Market by Applications (injections, oral rehydration salt (ORS), hemodialysis, peritoneal dialysis, & hemofiltration solutions, channeling agents/ osmotic agent, mechanical cleansing solutions, dietary formulations and infant formulations), by Region - Industry Trends & Forecasts to 2019", published by MarketsandMarkets, The Pharmaceutical Grade Sodium Chloride Market is projected to grow at a CAGR of 12.9% to reach $295.35 Million by 2019.
Browse 72 market data Tables and 41 Figures spread through119 Pages and in-depth TOC on"Pharmaceutical Grade Sodium Chloride Market".
http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-grade-sodium-chloride-market-64974587.html
Early buyers will receive 10% customization on this report.
The global pharmaceutical grade sodium chloride market with analysis and forecasting of volume consumed and value generated. The pharmaceutical grade sodium chloride market, in terms of volume is projected to reach 690 KT by 2019, registering a CAGR of 6.9% during the forecast period.
The report also defines driving and restraining factors for the global pharmaceutical grade sodium chloride market with the analysis of trends, opportunities, burning issues, winning imperatives, and challenges. Some of the drivers include increased spending in healthcare sector in developed countries and the growing awareness in developing countries. The pharmaceutical grade sodium chloride market is experiencing faster growth rate, especially in Asia-Pacific, due to the increased demands of IV solutions and dialysis solutions in emerging markets.
The market is forecasted on the basis of major regions, such as North America, Europe, Asia-Pacific, and Rest of the World both by value and volume. The regional pharmaceutical grade sodium chloride market is further segmented on the basis of its major applications.
"North America: The Biggest Market of Pharmaceutical grade sodium chloride"
The North-America region was the world's largest market for pharmaceutical grade sodium chloride in terms of volume in 2013. United States was the key consumers of pharmaceutical grade sodium chloride in the North-America.
Various expansions and joint ventures in the pharmaceutical grade sodium chloride industry, growing demands from the injections, dialysis, and pharmaceutical formulations and will drive the pharmaceutical grade salt market. Abundant availability and demand have in turn made the North American region a potential growth market for pharmaceutical grade sodium chloride market.
For Further Inquiry:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=64974587
Expansion and joint ventures are the major growth strategies adopted by industry players. Most of the companies are engaged in expanding their existing facilities to abide increasing demands from various end-use applications.
The report forecasts value of the global pharmaceutical grade sodium chloride market and its various sub-markets with respect to main regions namely, Asia-Pacific, Europe, North America, and Rest of the World.
The report segments the global pharmaceutical grade sodium chloride market by its end-use applications in different regions.
Browse Related Reports:
Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html
Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) - Global Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Chemical Domain @ http://www.marketsandmarkets.com/Subscription.html
Contact:
Mr.Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @http://www.marketsandmarketsblog.com/market-reports/chemical
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
